Anectine (succinylcholine chloride) NDC 0781-3411

NDC codes

FDA NDC Directory

Product NDC (as listed)0781-3411Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00781-3411Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0781-3411-95	00781341195	10 VIAL, MULTI-DOSE in 1 CARTON (0781-3411-95) / 10 mL in 1 VIAL, MULTI-DOSE (0781-3411-70)Marketed from Jun 22, 2017

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Anectine
Generic name (nonproprietary): succinylcholine chloride
Active ingredients: Succinylcholine chloride — 20 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous, Parenteral
Labeler: Sandoz Inc
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 008453
Marketing start: Jun 22, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Neuromuscular Depolarizing Blockade (Physiologic effect)
Identifiers: Product ID 0781-3411_38c016c1-43d4-4221-b087-48d2458d5adcSPL ID 38c016c1-43d4-4221-b087-48d2458d5adcSPL set ID a1e5d29f-111e-4a44-addf-beeb6ea81711RxCUI 1594589, 1594591UNII I9L0DDD30I
Pharmacologic class: Depolarizing Neuromuscular Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400781341195 followed by a unit qualifier and the quantity

Package 00781-3411-95. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 29, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

ANECTINE is indicated in adults and pediatric patients: • as an adjunct to general anesthesia • to facilitate tracheal intubation • to provide skeletal muscle relaxation during surgery or mechanical ventilation. ANECTINE is a depolarizing neuromuscular blocker indicated in adults and pediatric patients: • as an adjunct to general anesthesia ( 1 ) • to facilitate tracheal intubation ( 1 ) • to provide skeletal muscle relaxation during surgery or mechanical ventilation ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 008453

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 008453
Product	Strength	Form · route	Labeler	Product NDC
Anectinesuccinylcholine chloride	Succinylcholine chloride 20 mg/mL	Injection, SolutionIntramuscular, Intravenous, Parenteral	Sandoz Inc	0781-9053
Anectinesuccinylcholine chloride	Succinylcholine chloride 20 mg/mL	Injection, SolutionIntramuscular, Intravenous, Parenteral	Civica, Inc.	72572-750